Nuclear Security & Deterrence Monitor Vol. 28 No. 10
Visit Archives | Return to Issue PDF
Visit Archives | Return to Issue PDF
Nuclear Security & Deterrence Monitor
Article 3 of 6
March 08, 2024
NNSA to help fund Shine Technologies new medical isotope production facility
The NNSA intends to grant SHINE Technologies cost-share funding to build and operate a new facility for producing the medical isotope molybdenum-99 (Mo-99) without the use of highly-enriched uranium, according to a March 4 filing in the Federal Register.
The agency…
Partner Content